Viewing Study NCT02662712


Ignite Creation Date: 2025-12-26 @ 11:08 AM
Ignite Modification Date: 2026-02-24 @ 11:00 AM
Study NCT ID: NCT02662712
Status: COMPLETED
Last Update Posted: 2025-02-03
First Post: 2015-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II)
Sponsor: Janssen Sciences Ireland UC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-12-17
Start Date Type: ACTUAL
Primary Completion Date: 2018-06-29
Primary Completion Date Type: ACTUAL
Completion Date: 2018-06-29
Completion Date Type: ACTUAL
First Submit Date: 2015-12-02
First Submit QC Date: None
Study First Post Date: 2016-01-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-01-31
Last Update Post Date: 2025-02-03
Last Update Post Date Type: ACTUAL